Michael Charles Ferguson Hannay
CIK: 0002015378
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BICYCLE THERAPEUTICS PLC
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Oct 5, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct242 shares at avg. $3.57$863.94 - Oct 2, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct1.6K shares at avg. $3.47$5K - Jul 15, 2026BCYC
BICYCLE THERAPEUTICS PLC
Award(A)DirectEmployee Stock Option (right to buy)
60K shares- - Jul 6, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct255 shares at avg. $4.31$1K - Jul 2, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct1.5K shares at avg. $4.27$6K - Apr 6, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct251 shares at avg. $5.05$1K - Apr 2, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct1.5K shares at avg. $4.91$7K - Jan 5, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct2.4K shares at avg. $6.45$15K - Jan 2, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct2.8K shares at avg. $6.80$19K - Jan 2, 2026BCYC
BICYCLE THERAPEUTICS PLC
Award(A)Direct50K shares- - Oct 3, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct250 shares at avg. $8.41$2K - Oct 2, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct473 shares at avg. $8.40$4K - Jul 3, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct248 shares at avg. $7.44$2K - Jul 2, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct474 shares at avg. $7.09$3K - Apr 3, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct266 shares at avg. $7.48$2K - Apr 2, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct467 shares at avg. $8.02$4K - Jan 3, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct239 shares at avg. $14.75$4K - Jan 2, 2025BCYC
BICYCLE THERAPEUTICS PLC
Award(A)Direct35K shares- - Jan 2, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct1.9K shares at avg. $14.09$26K - Oct 3, 2024BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct247 shares at avg. $22.26$5K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 5, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 242 | $3.57 | $864 | Direct |
| Oct 2, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 1,572 | $3.47 | $5,455 | Direct |
| Jul 15, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Award(A) Employee Stock Option (right to buy) | 60,000 | - | - | Direct |
| Jul 6, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 255 | $4.31 | $1,099 | Direct |
| Jul 2, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 1,506 | $4.27 | $6,431 | Direct |
| Apr 6, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 251 | $5.05 | $1,268 | Direct |
| Apr 2, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 1,521 | $4.91 | $7,468 | Direct |
| Jan 5, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 2,367 | $6.45 | $15,267 | Direct |
| Jan 2, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 2,827 | $6.80 | $19,224 | Direct |
| Jan 2, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Award(A) | 50,000 | - | $0 | Direct |
| Oct 3, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 250 | $8.41 | $2,103 | Direct |
| Oct 2, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 473 | $8.40 | $3,973 | Direct |
| Jul 3, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 248 | $7.44 | $1,845 | Direct |
| Jul 2, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 474 | $7.09 | $3,361 | Direct |
| Apr 3, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 266 | $7.48 | $1,990 | Direct |
| Apr 2, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 467 | $8.02 | $3,745 | Direct |
| Jan 3, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 239 | $14.75 | $3,525 | Direct |
| Jan 2, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Award(A) | 35,000 | - | $0 | Direct |
| Jan 2, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 1,879 | $14.09 | $26,475 | Direct |
| Oct 3, 2024 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 247 | $22.26 | $5,498 | Direct |
1-20 of 20 transactions
About Hannay Michael Charles Ferguson
Hannay Michael Charles Ferguson (SEC CIK 0002015378) files insider reports with the SEC as CHIEF PROD & SUPPLY CHAIN OFF of BICYCLE THERAPEUTICS PLC (BCYC).
Signal8 holds 10 ownership filings by Hannay Michael Charles Ferguson, all Form 4s, filed between Oct 4, 2024 and Oct 6, 2026. Those filings report 20 transactions, from Oct 3, 2024 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hannay Michael Charles Ferguson's filings is in CAMBRIDGE.
Recent filings by Hannay Michael Charles Ferguson
- Oct 5, 2026: Open-market sale of BCYC shares (Form 4, code S).
- Oct 2, 2026: Open-market sale of BCYC shares (Form 4, code S).
- Jul 15, 2026: Grant or award of BCYC derivative securities (Form 4, code A).
- Jul 6, 2026: Open-market sale of BCYC shares (Form 4, code S).
- Jul 2, 2026: Open-market sale of BCYC shares (Form 4, code S).
Other insiders filing for BICYCLE THERAPEUTICS PLC (BCYC)
- Perry Jennifer Scott, Chief Operating Officer
- Swanton Robert Charles, Director
- Skynner Michael, CHIEF SCIENTIFIC OFFICER
- Lee Kevin, CHIEF EXECUTIVE OFFICER
- Thompson Travis Alvin, Chief Financial Officer
- Milnes Alistair, CHIEF OPERATING OFFICER